CAT
Caterpillar Inc.
CAT has the edge over GENC overall, supported by stronger modeled upside and stronger fundamentals.
GENC
Gencor Industries, Inc.
GENC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
GENC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Strong |
GENC's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
GENC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $14.16 | -20% |
| Current | 17x | $17.62 | — |
| Fair | 18x | $18.30 | +3.9% |
| Expensive | 39x | $39.17 | +122% |
Historical ranges are pointers, not guarantees.
GENC has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
GENC Forward outlook
There aren't enough analyst estimates for GENC to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
GENC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.01 | -2.9% |
| Q1 2026 | $0.88 | -7.4% |
| Q4 2025 | $1.04 | +9.5% |
| Q3 2025 | $1.07 | +8.1% |
| Q2 2025 | $1.04 | -5.5% |
| Q1 2025 | $0.95 | -17% |
| Q4 2024 | $0.95 | -10% |
| Q3 2024 | $0.99 | -1% |
GENC earned $1.01 per share over the past year, down 2.9% from the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over GENC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over GENC on profitability, with a higher operating margin.
GENC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $33.8M | +25% |
| Q1 2026 | $33.8M | -12% |
| Q4 2025 | $23.6M | -25% |
| Q3 2025 | $18.8M | -10% |
| Q2 2025 | $27M | +5.6% |
| Q1 2025 | $38.2M | -6.1% |
| Q4 2024 | $31.4M | +21% |
| Q3 2024 | $20.9M | +0.2% |
GENC's revenue is recovering but still below its 2024 peak: $34M last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | +5.5 points |
| Q1 2026 | 13% | -4.4 points |
| Q4 2025 | 13% | -1.6 points |
| Q3 2025 | -1.2% | -7.1 points |
| Q2 2025 | 12% | +3.8 points |
| Q1 2025 | 17% | -0.4 points |
| Q4 2024 | 15% | +1.7 points |
| Q3 2024 | 5.9% | -7 points |
GENC's operating margin was 17% last quarter, up 5.5 points from the same quarter a year ago, near the top of its range since 2019.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over GENC on cash generation, producing positive trailing cash flow while its opponent burns cash.
GENC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$17.2M | +$7.2M |
| Q1 2026 | $6.7M | -45% |
| Q4 2025 | $10.1M | -30% |
| Q3 2025 | -$1.3M | +$2M |
| Q2 2025 | -$24.4M | -$23M |
| Q1 2025 | $12.3M | +5.5% |
| Q4 2024 | $14.5M | +848% |
| Q3 2024 | -$3.3M | -130% |
GENC's free cash flow was −$2M over the past year, against −$906,000 the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over GENC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
GENC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | -- |
| 5 years | -0.6% | -91K shares |
| Available history | -0.3% | -50K shares |
GENC has 15M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q3 2024 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
GENC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -3.0x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -2.7x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
GENC has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GENC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 48.4 | Neutral |
GENC's weekly RSI is 58 (neutral) and its Stochastic is 48 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
GENC PE vs Industrials Sector
| Metric | GENC | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 24x | 28% below |
| PE % | 45 | 58 | 13 pts below |
GENC has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
GENC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.5 | 0.7% above |
| 20 week MA | $17.0 | 3.6% above |
| 50 week MA | $15.5 | 14% above |
| 100 week MA | $14.9 | 18% above |
| 200 week MA | $15.8 | 12% above |
GENC has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
GENC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.8 | $11.8 | 0% |
| 2021 | $11.8 | $11.6 | -1.6% |
| 2022 | $11.6 | $10.4 | -10% |
| 2023 | $10.4 | $16.1 | +55% |
| 2024 | $16.1 | $17.4 | +7.8% |
| 2025 | $17.4 | $12.6 | -28% |
| 2026 YTD | $12.6 | $17.6 | +40% |
GENC has the edge over CAT on returns for 2026, with the stronger performance.